Vincent Fabien

2.1k total citations
23 papers, 610 citations indexed

About

Vincent Fabien is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Vincent Fabien has authored 23 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 11 papers in Hematology and 4 papers in Immunology. Recurrent topics in Vincent Fabien's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Erythropoietin and Anemia Treatment (6 papers) and Iron Metabolism and Disorders (6 papers). Vincent Fabien is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Erythropoietin and Anemia Treatment (6 papers) and Iron Metabolism and Disorders (6 papers). Vincent Fabien collaborates with scholars based in United Kingdom, Germany and Italy. Vincent Fabien's co-authors include Hilary Longhurst, Marcus Maurer, Andrea Zanichelli, Teresa Caballero, Werner Aberer, Laurence Bouillet, Markus Magerl, Gisèle Kanny, Allen P. Kaplan and E Grosshans and has published in prestigious journals such as Circulation, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Vincent Fabien

22 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent Fabien United Kingdom	14	441	203	157	150	134	23	610
Dacao Gao United States	6	380 0.9×	76 0.4×	323 2.1×	22 0.1×	98 0.7×	10	596
Grant McQuaker United Kingdom	11	144 0.3×	36 0.2×	319 2.0×	172 1.1×	125 0.9×	21	548
Loredana Lupica Italy	7	271 0.6×	91 0.4×	313 2.0×	17 0.1×	25 0.2×	11	547
Elvira Deolinda Rodrigues Pereira Velloso Brazil	13	209 0.5×	129 0.6×	423 2.7×	70 0.5×	88 0.7×	81	654
Soken-Nakazawa J. Song Japan	5	133 0.3×	82 0.4×	212 1.4×	22 0.1×	54 0.4×	8	364
Rafael Marino Canada	7	142 0.3×	57 0.3×	76 0.5×	46 0.3×	123 0.9×	11	369
C. Feighery Ireland	8	54 0.1×	78 0.4×	68 0.4×	35 0.2×	125 0.9×	15	319
M. Guzail United Kingdom	7	112 0.3×	54 0.3×	146 0.9×	25 0.2×	22 0.2×	9	354
Haruka Iwao Japan	12	46 0.1×	149 0.7×	99 0.6×	34 0.2×	49 0.4×	22	472
Miyuki Miki Japan	11	38 0.1×	108 0.5×	96 0.6×	32 0.2×	47 0.4×	20	363

Countries citing papers authored by Vincent Fabien

Since Specialization

Citations

This map shows the geographic impact of Vincent Fabien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Fabien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Fabien more than expected).

Fields of papers citing papers by Vincent Fabien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Fabien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Fabien. The network helps show where Vincent Fabien may publish in the future.

Co-authorship network of co-authors of Vincent Fabien

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Fabien. A scholar is included among the top collaborators of Vincent Fabien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Fabien. Vincent Fabien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosano, Giuseppe, Piotr Ponikowski, Cristiana Vitale, et al.. (2023). Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial. Cardiovascular Diabetology. 22(1). 215–215.

Butler, Javed, Muhammad Shahzeb Khan, Tim Friede, et al.. (2022). Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency. European Journal of Heart Failure. 24(5). 821–832. 11 indexed citations

Anker, Stefan D., Piotr Ponikowski, Muhammad Shahzeb Khan, et al.. (2022). Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency. European Journal of Heart Failure. 24(5). 833–842. 7 indexed citations

Metra, Marco, Ewa A. Jankowska, Matteo Pagnesi, et al.. (2022). Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial. European Journal of Heart Failure. 24(10). 1928–1939. 20 indexed citations

Filippatos, Gerasimos, Piotr Ponikowski, Dimitrios Farmakis, et al.. (2021). Efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency with and without anaemia: a subgroup analysis of AFFIRM-AHF. European Heart Journal. 42(Supplement_1). 1 indexed citations

Rosano, Giuseppe, et al.. (2020). A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose. Journal of Clinical Medicine. 9(11). 3587–3587. 24 indexed citations

Longhurst, Hilary, John Dempster, Lorena Lorenzo, et al.. (2018). Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom. Allergy Asthma and Clinical Immunology. 14(1). 28–28. 8 indexed citations

Bouillet, Laurence, Isabelle Boccon‐Gibod, David Launay, et al.. (2017). Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant. Immunity Inflammation and Disease. 5(1). 29–36. 25 indexed citations

Caballero, Teresa, Marcus Maurer, Hilary Longhurst, et al.. (2016). Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema. Journal of Investigational Allergology and Clinical Immunology. 26(6). 383–386. 61 indexed citations

10.

Zanichelli, Andrea, Marcus Maurer, Werner Aberer, et al.. (2016). Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice. Allergy. 72(6). 994–998. 14 indexed citations

11.

Longhurst, Hilary, Andrea Zanichelli, Teresa Caballero, et al.. (2016). Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey. Clinical & Experimental Immunology. 188(1). 148–153. 28 indexed citations

12.

Longhurst, Hilary, Werner Aberer, Laurence Bouillet, et al.. (2015). Analysis of characteristics associated with reinjection of icatibant: Results from the Icatibant Outcome Survey. Allergy and Asthma Proceedings. 36(5). 399–406. 15 indexed citations

13.

Rojas, Dolores Hernández Fernández de, Hilary Longhurst, Marcus Maurer, et al.. (2015). Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals. International Archives of Allergy and Immunology. 167(1). 21–28. 34 indexed citations

14.

Zanichelli, Andrea, Hilary Longhurst, Marcus Maurer, et al.. (2015). History of Misdiagnosis in Patients with Hereditary Angioedema Participating in the Icatibant Outcome Survey. Journal of Allergy and Clinical Immunology. 135(2). AB194–AB194. 1 indexed citations

15.

Maurer, Marcus, et al.. (2014). Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting. Allergy and Asthma Proceedings. 35(5). 377–381. 17 indexed citations

16.

Zanichelli, Andrea, Markus Magerl, Hilary Longhurst, Vincent Fabien, & Marcus Maurer. (2013). Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe. Allergy Asthma and Clinical Immunology. 9(1). 29–29. 109 indexed citations

17.

Maurer, Marcus, Werner Aberer, Laurence Bouillet, et al.. (2013). Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment. PLoS ONE. 8(2). e53773–e53773. 113 indexed citations

18.

Maurer, Marcus, Werner Aberer, Laurence Bouillet, et al.. (2013). Correction: Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment. PLoS ONE. 8(8). 6 indexed citations

19.

Cribier, B., et al.. (1998). Nail Changes in Patients Infected With Human Immunodeficiency Virus. Archives of Dermatology. 134(10). 1216–20. 71 indexed citations

20.

Fabien, Vincent, et al.. (1996). Caries prevalence and salt fluoridation among 9‐year‐old schoolchildren in Strasbourg, France. Community Dentistry And Oral Epidemiology. 24(6). 408–411. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact